Shock as CMA rules no 'further remedies' for private hospitals
The Competition and Markets (Authority) has concluded following new evidence, that extra remedies in London's private healthcare market such as price controls would not be proportionate as part of its investigation into the UK private healthcare market.
Two of the CMA members dissented from this decision. Insurer Bupa described the final decision from the watchdog as "extraordinary" and it "had failed to find a solution." The Competition Commission, a predecessor body of the Competition and Markets Authority (CMA), started a market investigation into private healthcare in April 2012, which reported in April 2014, immediately after the establishment of the CMA. The report concluded that certain features of the markets for privately-funded...
More on PMI
MoneySuperMarket adds PMI price comparison service
Comparison services join forces
Emma Thomson: 'Facebook saved my life'
COVER podcast #2
Vitality's American Express cashback card explained
3% cashback each month
Industry reacts to Labour promise of 'free' dental care
'You can tell it's general election season'
